Breast: Hungarian experience and european trend

Research output: Chapter in Book/Report/Conference proceedingChapter


Before the era of breast-conserving therapy, BT implants were used to treat large inoperable breast tumors. Later interstitial BT has been used to deliver an additional dose to the tumor bed after BCS and WBI. Based on the obvious dosimetric advantages of interstitial breast implants (over external beam techniques) supported by the encouraging results of modern boost series utilizing stepping-source afterloading technology, multicatheter HDR/PDR BT remains a standard treatment option for boosting the tumor bed after BCS and WBI. APBI is an attractive treatment approach with considerable advantages over conventional WBI opening new prospects for interstitial breast BT. Contemporary APBI trials using interstitial BT with strict patient selection criteria resulted in an annual LR rate <1%. Development of new standards for 3D CT image-based BT treatment planning together with the implementation of inverse dose planning will further improve the conformity of dose distribution delivered by multicatheter implants maximizing the ballistic advantage of interstitial breast BT.

Original languageEnglish
Title of host publicationBrachytherapy
Subtitle of host publicationTechniques and Evidences
PublisherSpringer Singapore
Number of pages14
ISBN (Electronic)9789811304903
ISBN (Print)9789811304897
Publication statusPublished - Jan 1 2018



  • Accelerated partial breast irradiation
  • Brachytherapy
  • Breast-conserving therapy
  • Radiotherapy
  • Tumor bed boost

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Polgár, C. (2018). Breast: Hungarian experience and european trend. In Brachytherapy: Techniques and Evidences (pp. 221-234). Springer Singapore.